Shared decision-making in advanced kidney disease: a scoping review
Open Access
Abstract
Objectives: To provide a comprehensive overview of interventions that support shared decision-making (SDM) for treatment modality decisions in advanced kidney disease (AKD). To provide summarised information on their content, use and reported results. To provide an overview of interventions currently under development or investigation.Design: The JBI methodology for scoping reviews was followed. This review conforms to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) checklist.Data sources: MEDLINE, Embase, Web of Science, Cochrane Library, Emcare, PsycINFO, PROSPERO and Academic Search Premier for peer-reviewed literature. Other online databases (eg, clinicaltrials.gov, OpenGrey) for grey literature.Eligibility for inclusion: Records in English with a study population of patients >18 years of age with an estimated glomerular filtration rate 2. Records had to be on the subject of SDM, or explicitly mention that the intervention reported on could be used to support SDM for treatment modality decisions in AKD.Data extraction and synthesis: Two reviewers independently screened and selected records for data extraction. Interventions were categorised as prognostic tools (PTs), educational programmes (EPs), patient decision aids (PtDAs) or multicomponent initiatives (MIs). Interventions were subsequently categorised based on the decisions they were developed to support.Results: One hundred forty-five interventions were identified in a total of 158 included records: 52 PTs, 51 EPs, 29 PtDAs and 13 MIs. Sixteen (n=16, 11%) were novel interventions currently under investigation. Forty-six (n=46, 35.7%) were reported to have been implemented in clinical practice. Sixty-seven (n=67, 51.9%) were evaluated for their effects on outcomes in the intended users.Conclusion: There is no conclusive evidence on which intervention is the most efficacious in supporting SDM for treatment modality decisions in AKD. There is a lot of variation in selected outcomes, and the body of evidence is largely based on observational research. In addition, the effects of these interventions on SDM are under-reported.Keywords
Funding Information
- ZonMw (516007001)
This publication has 149 references indexed in Scilit:
- Development of a decision aid to inform patients’ and families’ renal replacement therapy selection decisionsBMC Medical Informatics and Decision Making, 2012
- Effectiveness of multimedia interactive patient education on knowledge, uncertainty and decision‐making in patients with end‐stage renal diseaseJournal of Clinical Nursing, 2011
- What influences patient choice of treatment modality at the pre-dialysis stage?Nephrology Dialysis Transplantation, 2011
- Effective implementation of research into practice: an overview of systematic reviews of the health literatureBMC Research Notes, 2011
- Effect of an In-Hospital Chronic Kidney Disease Education Program among Patients with Unplanned Urgent-Start DialysisClinical Journal of the American Society of Nephrology, 2011
- Dedication of a nurse to educating suboptimal haemodialysis starts improved transition to independent modalities of renal replacement therapyNephrology Dialysis Transplantation, 2010
- An integrated review of "unplanned" dialysis initiation: reframing the terminology to "suboptimal" initiationBMC Nephrology, 2009
- A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal diseaseNephrology Dialysis Transplantation, 2008
- Why do patients choose self-care dialysis?Nephrology Dialysis Transplantation, 2008
- Prediction of early death in end-stage renal disease patients starting dialysisAmerican Journal of Kidney Diseases, 1997